Hildred Capital Management closed its third fund, Hildred Equity Partners III, raising over $800m.
The fund, which surpassed its $600m target and reached its hard cap in seven months, is more than double the size of its predecessor, which closed in 2021 with $363m.
The fund received backing from a diverse range of investors, including public pension plans, financial institutions, endowments, private wealth platforms, family offices, and high-net-worth individuals. Hildred’s General Partners and affiliated entities also contributed over $60m, reflecting their confidence in the fund’s strategy.
Hildred will focus on healthcare subsectors with strong growth potential, including pharmaceuticals, care delivery, medical devices, diagnostics, and healthcare IT. The firm plans to pursue control-oriented investments in companies that enhance patient outcomes, increase access to quality care, and reduce costs.
Evercore Private Funds Group acted as the lead global placement agent, while Kirkland & Ellis provided legal counsel. The fund will begin deploying capital in Q1 2025 and is actively seeking investment opportunities.
This milestone highlights Hildred’s growing reputation in lower middle-market healthcare investing and its commitment to driving value through strategic, operational, and financial expertise.
Source: Hildred
Can’t stop reading? Read more
Quadrivio Group acquires majority stake in Les Secrets de Loly through Made in Italy Fund II
Quadrivio Group acquires majority stake in Les Secrets de Loly through Made in Italy Fund II...
Warburg Pincus explores sale or partnership for Southeast Asian insurer Oona
Warburg Pincus explores sale or partnership for Southeast Asian insurer Oona Warburg Pincus is...
I Squared Capital nears $10bn for flagship infrastructure fund amid sector boom
I Squared Capital nears $10bn for flagship infrastructure fund amid sector boom I Squared Capital...